TrialBlood2021
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Elisabeth Paietta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this papertrialcites it
TrialBlood2021
Elisabeth Paietta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.